4basebio Plc () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Diaceutics Plc

Oxford Biomedica Plc

Optibiotix Health Plc

Scancell Holdings Plc

Oxford BioDynamics Plc

Ondine Biomedical, Inc.

PureTech Health Plc

4basebio Plc

e-Therapeutics Plc

HemoGenyx Pharmaceuticals Plc

Oncimmune Holdings Plc

Why is 4basebio Plc ?

Poor Management Efficiency with a low ROE of 2.04%

The company has been able to generate a Return on Equity (avg) of 2.04% signifying low profitability per unit of shareholders funds

The company is Net-Debt Free

Poor long term growth as Operating profit has grown by an annual rate -197.78% of over the last 5 years
The company is Net-Debt Free
The company has been able to generate a Return on Equity (avg) of 2.04% signifying low profitability per unit of shareholders funds

Poor long term growth as Operating profit has grown by an annual rate -197.78% of over the last 5 years

Negative results in Dec 25

OPERATING CASH FLOW(Y) Lowest at GBP -25.5 MM
DEBT-EQUITY RATIO (HY) Highest at -12.84 %
PRE-TAX PROFIT(Q) Lowest at GBP -9.38 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -46.70%, its profits have fallen by -100.8%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is 4basebio Plc for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

4basebio Plc

-46.7%

-1.80

36.42%

FTSE 100

17.87%

1.52

11.77%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

25.77%

EBIT Growth (5y)

-197.78%

EBIT to Interest (avg)

-3.83

Debt to EBITDA (avg)

1.10

Net Debt to Equity (avg)

-0.74

Sales to Capital Employed (avg)

35.25

Tax Ratio

89.59%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

2.04%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

8.07

EV to EBIT

-2.21

EV to EBITDA

3.37

EV to Capital Employed

9.80

EV to Sales

0.17

PEG Ratio

Dividend Yield

ROCE (Latest)

-442.51%

ROE (Latest)

-1.66%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

No Trend

Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

NET PROFIT(HY)

Higher at GBP -9.1 MM

RAW MATERIAL COST(Y)

Fallen by -22.62% (YoY

-16What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at GBP -25.5 MM

DEBT-EQUITY RATIO (HY)

Highest at -12.84 %

PRE-TAX PROFIT(Q)

Lowest at GBP -9.38 MM

NET PROFIT(Q)

Lowest at GBP -9.1 MM

EPS(Q)

Lowest at GBP -0.59

Here's what is working for 4basebio Plc

Raw Material Cost

Fallen by -22.62% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for 4basebio Plc

Pre-Tax Profit

At GBP -9.38 MM has Fallen at -44.06%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (GBP MM)

Operating Cash Flow

Lowest at GBP -25.5 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (GBP MM)

Pre-Tax Profit

Lowest at GBP -9.38 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (GBP MM)

Net Profit

Lowest at GBP -9.1 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (GBP MM)

Net Profit

At GBP -9.1 MM has Fallen at -37.79%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (GBP MM)

Debt-Equity Ratio

Highest at -12.84 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

EPS

Lowest at GBP -0.59

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (GBP)